SCHEMBL23055381

SCHEMBL23055381

CC(C)(O)c1cccc2c1CCN2

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.38
PARP1 P09874 3/20 0.34
PARP10 Q53GL7 2/20 0.34
PARP11 Q9NR21 2/20 0.34
CA2 P00918 1/20 0.32
CRBN Q96SW2 1/20 0.32
PKM P14618 1/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
BRD4 O60885 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13779510 0.85 NOTUM (0.40) NOTUMPARP1PARP10PARP11CA2
SCHEMBL24841674 0.79 NOTUM (0.40) NOTUMPARP1PARP10PARP11
SCHEMBL13952173 0.79 NOTUM (0.40) NOTUMPARP1PARP10PARP11BRD4
SCHEMBL30684831 0.78 NOTUM (0.40) NOTUMPARP1PKM
SCHEMBL3874122 0.78 NOTUM (0.40) NOTUMPARP1PKM
SCHEMBL19286543 0.77 NOTUM (0.38) NOTUMPARP1PARP10PARP11
SCHEMBL24854401 0.77 NOTUM (0.38) NOTUMPARP1PARP10PARP11BRD4
Hydrochloric Acid SCHEMBL28637723 0.76 NOTUM (0.39) NOTUMPARP1PKM
SCHEMBL9910074 0.75 GRIA1 (0.38) PARP1CA2DRD2BCHE
SCHEMBL30955293 0.74 MAP4K1 (0.30) NOTUMPARP10PARP11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133499-A1 GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) 2024-06-27 WO disclosed
WO-2021039961-A1 RING-FUSED PYRAZOLE DERIVATIVE 大日本住友製薬株式会社 2021-03-04 WO disclosed